Two new phosphorylation sites, p-tau262 and p-tau356, detect the formation of prefibrillar tau aggregates and may serve as early-stage biofluid-based biomarkers of tau neurofibrillary tangle pathology in Alzheimer’s disease. This evidence concerns the gene MAPT and Alzheimer disease.